3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
4
Completed
3
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Lymphoma
2
Primary Myelofibrosis
1
Polycythemia Vera
1
Nasopharyngeal Carcinoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Hereditary Sensory and Autonomic Neuropathies
1
Chordoma
1
Advanced Solid Tumors
1
Interventions
Azacitidine
10
Decitabine
9
Cyclophosphamide
9
Cytarabine
7
Tacrolimus
6
Antilymphocyte Serum
6
fludarabine phosphate
5
Mycophenolic Acid
5
Melphalan
5
Busulfan
5
fludarabine
4
Whole-Body Irradiation
4
Peripheral Blood Stem Cell Transplantation
4
Idarubicin
4
Rituximab
3
Polymerase Chain Reaction
3
Lenalidomide
3
Filgrastim
3
venetoclax
2
sargramostim
2
Tretinoin
2
Radiotherapy
2
Methylprednisolone
2
Methotrexate
2
Flow Cytometry
2
Etoposide
2
Cyclosporine
2
Cord Blood Stem Cell Transplantation
2
Clofarabine
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Myelodysplastic Syndromes
×
Panobinostat
×
Clear all
NCT01451268
2018-03-20
PANOBEST
Johann Wolfgang Goethe University Hospital
Phase 1/2
Unknown
62 enrolled